Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Piqray 200 mg film-coated tablets {equilateral_black_triangle}

Active Ingredient:
alpelisib
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
L01XX65
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Piqray-Educational material - Guide for healthcare professionals - Management of risk of hyperglycaemia - digital version

{healthcare_pro_orange} For Healthcare Professionals
The objective of these materials is to raise awareness of the increased risk of hyperglycaemia associated with alpelisib treatment, as well as to provide information concerning: - signs and symptoms of severe hyperglycaemia (including ketoacidosis) - monitoring required before and during treatment - management of hyperglycaemia associated with alpelisib

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442
E-mail
[email protected]